WinstonWınston
Back
Stock

Apotea AB

APOTEA.ST
50
Specialty Retail · Consumer Cyclical
Price
kr 74.90
-1.05 (-1.38%)
Market Cap
kr 7.79B
Exchange
Stockholm Stock Exchange
Winston Score
50
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Sep 10, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Good
Growth
Mixed
Cash Flow
Good
Stability
Good
Valuation
Good
Dividends
Mixed

Share count rising — dilution

+2.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 101.9M (2021) → 104.1M (2025)

§Winston Score History

The full picture

Apotea is Sweden's largest online pharmacy. It sells prescription medicines, over-the-counter drugs, vitamins, and health and beauty products directly to consumers through its website and app. The company operates a highly automated warehouse near Stockholm that lets it ship orders quickly across Sweden.

Apotea makes money by selling products at a markup, much like a traditional retailer but without expensive physical stores. This online-only model keeps costs low and helps the company offer competitive prices, which has built strong brand recognition and customer loyalty in Sweden. Its large customer base and efficient logistics give it a scale advantage over smaller competitors. Key growth opportunities include expanding its product range and potentially entering new Nordic markets, though increasing competition from both online and brick-and-mortar pharmacies remains a notable risk.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+10.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+13.0% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

kr 0/ year

0.0% of revenue

Below sector average (4%)

Research and development spending

Insider Activity

36.6%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

kr 104M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Apotea AB is a rare growth stock that's already generating positive cash flow while growing at 11%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
27.5%
Modest — 27.5% gross margin
Profit after running costs
Operating Margin
5.2%
Thin — 5.2% operating margin
Return on the money invested
ROCE
33.6%
Exceptional — 33.6% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+9.4%
Steady sales growth (+9.4% YoY)
Profit growth
EPS YoY
-91.9%
Earnings shrinking (-91.9% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/7 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
95%
Turns 95% of profit into real cash
Spare cash per sale
FCF Margin
2.0%
Thin free cash flow (2.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
26.10x
Comfortably covers interest (26.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
31.7x
Pricey — P/E 31.7

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+5.0
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (31.7 → 26.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.21%
Moderate income — 3.21% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial